Results of ANOVA showed no significant group or carryover effects for either AUC (FEV1)/h and maximum FEV1 (P = .50 and P = .59, respectively)
Procaterol hydrochloride inhaler
Approved inhaler
Period effects for AUC (FEV1)/h